Brief: Cti Biopharma Reports Q4 Loss Per Share Of $0.20

CTI Biopharma

17/03/2021 20:21

March 17 (Reuters) - CTI Biopharma Corp  CTIC.O :
    * CTI BIOPHARMA REPORTS FOURTH QUARTER AND FULL YEAR 2020
FINANCIAL RESULTS
    * Q4 LOSS PER SHARE $0.20
    * EXPECT OUR CURRENT CASH, CASH EQUIVALENTS AND SHORT-TERM
INVESTMENTS WILL ENABLE US TO FUND OUR OPERATIONS INTO Q2 OF
2021

Source text for Eikon:  ID:nPn70JT7la 
Further company coverage:  CTIC.O 

 ((Reuters.Briefs@thomsonreuters.com;))